Evolv Technologies (EVLV) Financials

$5.92 +0.38 (+6.77%)

As of 01:34 PM Eastern

Annual Income Statements for Evolv Technologies

This table shows Evolv Technologies' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021
Net Income / (Loss) Attributable to Common Shareholders	-54	-106	-86	-11
Consolidated Net Income / (Loss)	-54	-106	-86	-11
Net Income / (Loss) Continuing Operations	-54	-106	-86	-11
Total Pre-Tax Income	-54	-106	-86	-11
Total Operating Income	-82	-88	-103	-55
Total Gross Profit	59	34	1.73	4.03
Total Revenue	104	80	55	23
Operating Revenue	104	80	55	23
Total Cost of Revenue	45	47	53	19
Total Operating Expenses	142	122	104	59
Selling, General & Admin Expense	57	42	38	20
Marketing Expense	61	55	47	26
Research & Development Expense	23	24	19	11
Impairment Charge	0.22	0.32	1.16	1.87
Total Other Income / (Expense), net	28	-18	16	44
Interest Expense	0.00	1.28	0.71	19
Interest & Investment Income	2.94	6.23	3.17	0.00
Other Income / (Expense), net	25	-23	14	63
Income Tax Expense	0.00	0.05	0.00	-
Basic Earnings per Share	($0.34)	($0.71)	($0.60)	($0.15)
Weighted Average Basic Shares Outstanding	156.57M	149.17M	143.86M	71.66M
Diluted Earnings per Share	($0.34)	($0.71)	($0.60)	($0.15)
Weighted Average Diluted Shares Outstanding	156.57M	149.17M	143.86M	71.66M

This table shows Evolv Technologies' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	3.42	-12	-17	6.00	-67	-29	-28	-19
Consolidated Net Income / (Loss)	3.46	-12	-17	6.00	-67	-29	-28	-19
Net Income / (Loss) Continuing Operations	3.46	-12	-17	6.00	-67	-29	-28	-19
Total Pre-Tax Income	3.46	-12	-17	6.00	-67	-29	-28	-19
Total Operating Income	-22	-22	-22	-20	-24	-22	-27	-27
Total Gross Profit	14	12	10	11	7.41	4.77	0.05	0.23
Total Revenue	26	22	22	20	20	19	21	17
Operating Revenue	26	22	22	20	20	19	21	17
Total Cost of Revenue	11	9.90	12	8.80	12	14	21	16
Operating Cost of Revenue	11	-	-	-	12	-	-	-
Total Operating Expenses	37	34	32	32	31	27	27	27
Selling, General & Admin Expense	14	12	11	11	11	8.93	8.45	8.84
Marketing Expense	17	16	15	14	14	13	13	12
Research & Development Expense	5.72	6.21	6.26	6.41	6.40	5.39	4.82	5.62
Impairment Charge	0.00	0.00	-	0.03	0.16	0.14	0.12	0.63
Total Other Income / (Expense), net	26	11	5.07	26	-43	-6.12	-1.49	7.99
Interest Expense	0.00	0.00	-	0.00	0.00	1.28	0.22	0.19
Interest & Investment Income	0.68	1.09	1.63	1.79	1.85	0.95	1.55	1.05
Other Income / (Expense), net	25	9.55	3.44	24	-45	-5.79	-2.82	7.12
Basic Earnings per Share	$0.02	($0.08)	($0.10)	$0.04	($0.45)	($0.20)	($0.19)	($0.13)
Weighted Average Basic Shares Outstanding	156.47M	153.08M	149.17M	150.21M	148.88M	146.43M	143.86M	144.12M
Diluted Earnings per Share	$0.02	($0.08)	($0.09)	$0.03	($0.45)	($0.20)	($0.19)	($0.13)
Weighted Average Diluted Shares Outstanding	171.56M	153.08M	149.17M	173.98M	148.88M	146.43M	143.86M	144.12M
Weighted Average Basic & Diluted Shares Outstanding	157.55M	156.09M	152.18M	151.13M	149.99M	148.43M	147.96M	144.62M

This table details how cash moves in and out of Evolv Technologies' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021
Net Change in Cash & Equivalents	-30	-163	-78	303
Net Cash From Operating Activities	-31	-9.80	-75	-57
Net Cash From Continuing Operating Activities	-31	-9.80	-75	-57
Net Income / (Loss) Continuing Operations	-54	-106	-86	-11
Consolidated Net Income / (Loss)	-54	-106	-86	-11
Depreciation Expense	17	9.93	5.47	2.90
Amortization Expense	0.45	-0.58	0.00	-
Non-Cash Adjustments To Reconcile Net Income	5.59	50	13	-38
Changes in Operating Assets and Liabilities, net	-0.25	37	-6.29	-11
Net Cash From Investing Activities	-1.40	-123	-24	-18
Net Cash From Continuing Investing Activities	-1.40	-123	-24	-18
Purchase of Property, Plant & Equipment	-37	-73	-24	-18
Purchase of Investments	-29	-90	0.00	-
Sale of Property, Plant & Equipment	0.00	0.27	0.31	0.00
Sale and/or Maturity of Investments	65	39	0.00	-
Net Cash From Financing Activities	1.81	-30	21	378
Net Cash From Continuing Financing Activities	1.81	-30	21	378
Repayment of Debt	0.00	-32	-10	-5.78
Issuance of Debt	0.00	1.88	30	32
Other Financing Activities, net	1.81	0.67	0.83	86
Effect of Exchange Rate Changes	0.02	-0.04	-0.01	0.00
Cash Interest Paid	0.00	0.71	0.58	0.85

This table details how cash moves in and out of Evolv Technologies' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	-8.90	-23	-33	-26	-55	-48	11	-24
Net Cash From Operating Activities	-22	-16	-3.14	2.10	-5.32	-3.43	-5.31	-17
Net Cash From Continuing Operating Activities	-22	-16	-3.14	2.10	-5.32	-3.43	-5.31	-17
Net Income / (Loss) Continuing Operations	3.46	-12	-17	6.00	-67	-29	-28	-19
Consolidated Net Income / (Loss)	3.46	-12	-17	6.00	-67	-29	-28	-19
Depreciation Expense	3.97	3.47	3.15	2.69	2.27	1.82	1.68	1.43
Amortization Expense	-0.02	0.20	-0.09	-0.24	-0.24	0.00	-	-
Non-Cash Adjustments To Reconcile Net Income	-15	-0.71	4.92	-18	51	12	14	-0.25
Changes in Operating Assets and Liabilities, net	-14	-7.41	5.77	11	8.65	11	7.49	0.50
Net Cash From Investing Activities	13	-6.79	-30	-29	-50	-14	-4.70	-6.50
Net Cash From Continuing Investing Activities	13	-6.79	-30	-29	-50	-14	-4.70	-6.50
Purchase of Property, Plant & Equipment	-3.04	-21	-19	-19	-21	-14	-4.70	-6.81
Sale and/or Maturity of Investments	16	29	20	20	-	0.00	-	-
Net Cash From Financing Activities	0.33	0.30	0.05	0.27	0.31	-30	21	-0.81
Net Cash From Continuing Financing Activities	0.33	0.30	0.05	0.27	0.31	-30	21	-0.81
Other Financing Activities, net	0.33	0.30	0.05	0.27	0.31	0.03	0.26	0.19
Effect of Exchange Rate Changes	0.01	0.00	-0.04	0.03	-0.02	-0.02	-0.05	0.05

This table presents Evolv Technologies' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021
Total Assets	268	299	348	363
Total Current Assets	121	176	293	331
Cash & Equivalents	37	67	230	307
Restricted Cash	0.00	0.28	0.00	0.40
Short-Term Investments	15	51	0.00	-
Accounts Receivable	28	23	32	6.48
Inventories, net	17	9.51	10	2.89
Prepaid Expenses	18	17	14	11
Other Current Assets	6.23	8.05	6.24	3.10
Plant, Property, & Equipment, net	124	113	45	24
Total Noncurrent Assets	23	9.96	11	7.95
Other Noncurrent Operating Assets	23	9.96	11	7.95
Total Liabilities & Shareholders' Equity	268	299	348	363
Total Liabilities	150	152	121	73
Total Current Liabilities	97	82	59	24
Accounts Payable	10	17	18	6.05
Accrued Expenses	20	16	12	9.55
Current Deferred Revenue	65	48	18	6.73
Other Current Liabilities	2.20	1.39	1.11	0.00
Total Noncurrent Liabilities	54	70	62	48
Noncurrent Deferred Revenue	20	24	18	2.81
Other Noncurrent Operating Liabilities	33	47	25	38
Commitments & Contingencies	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	118	146	227	290
Total Preferred & Common Equity	118	146	227	290
Preferred Stock	0.00	0.00	0.00	0.00
Total Common Equity	118	146	227	290
Common Stock	472	445	419	396
Retained Earnings	-355	-298	-192	-106
Accumulated Other Comprehensive Income / (Loss)	-0.03	-0.05	-0.01	0.00

This table presents Evolv Technologies' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	269	282	306	308	306	326
Total Current Assets	138	142	202	216	235	275
Cash & Equivalents	36	45	100	126	181	218
Restricted Cash	0.00	0.00	1.00	1.00	1.00	0.40
Short-Term Investments	21	36	39	30	-	-
Accounts Receivable	36	22	30	32	23	21
Inventories, net	19	11	7.83	5.03	8.82	6.73
Prepaid Expenses	20	21	17	14	14	20
Other Current Assets	6.50	7.05	7.58	8.38	6.56	7.70
Plant, Property, & Equipment, net	120	129	94	81	60	41
Total Noncurrent Assets	11	10	11	11	11	10
Other Noncurrent Operating Assets	11	10	11	11	11	10
Total Liabilities & Shareholders' Equity	269	282	306	308	306	326
Total Liabilities	115	141	150	164	102	77
Total Current Liabilities	79	80	81	68	51	41
Accounts Payable	5.57	16	14	17	19	11
Accrued Expenses	16	14	12	11	6.48	8.88
Current Deferred Revenue	56	49	53	39	24	16
Other Current Liabilities	1.75	1.71	1.66	1.13	1.12	1.11
Total Noncurrent Liabilities	36	61	70	96	51	36
Noncurrent Deferred Revenue	24	23	19	21	21	9.23
Other Noncurrent Operating Liabilities	12	38	50	75	30	22
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	153	142	156	144	204	248
Total Preferred & Common Equity	153	142	156	144	204	248
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	153	142	156	144	204	248
Common Stock	460	452	438	432	425	412
Retained Earnings	-307	-310	-282	-288	-221	-164
Accumulated Other Comprehensive Income / (Loss)	-0.04	-0.05	-0.01	-0.04	-0.03	0.04

This table displays calculated financial ratios and metrics derived from Evolv Technologies' official financial filings.

Metric	2024	2023	2022	2021
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021
Growth Metrics	-	-	-	-
Revenue Growth	30.54%	45.70%	135.95%	388.88%
EBITDA Growth	62.30%	-22.06%	-875.04%	141.66%
EBIT Growth	49.57%	-25.09%	-1,229.80%	129.24%
NOPAT Growth	8.60%	13.94%	-85.58%	-105.48%
Net Income Growth	50.01%	-22.97%	-693.59%	60.25%
EPS Growth	52.78%	-18.33%	-300.00%	95.11%
Operating Cash Flow Growth	-214.79%	86.88%	-31.61%	-144.18%
Free Cash Flow Firm Growth	-57.39%	41.24%	-293.50%	0.00%
Invested Capital Growth	158.55%	2.65%	450.38%	-292.50%
Revenue Q/Q Growth	0.00%	1.18%	34.92%	0.00%
EBITDA Q/Q Growth	0.00%	10.97%	-67.54%	0.00%
EBIT Q/Q Growth	0.00%	9.13%	-63.03%	0.00%
NOPAT Q/Q Growth	0.00%	5.27%	-7.07%	0.00%
Net Income Q/Q Growth	0.00%	9.70%	-62.07%	0.00%
EPS Q/Q Growth	0.00%	12.35%	-123.81%	0.00%
Operating Cash Flow Q/Q Growth	0.00%	18.09%	10.65%	-19.74%
Free Cash Flow Firm Q/Q Growth	0.00%	-46.05%	0.00%	0.00%
Invested Capital Q/Q Growth	0.00%	72.36%	-30.06%	0.00%
Profitability Metrics	-	-	-	-
Gross Margin	57.08%	42.07%	3.13%	17.22%
EBITDA Margin	-37.68%	-126.58%	-151.09%	46.00%
Operating Margin	-79.24%	-109.75%	-185.82%	-236.25%
EBIT Margin	-54.84%	-138.22%	-160.99%	33.62%
Profit (Net Income) Margin	-52.01%	-132.13%	-156.55%	-46.54%
Tax Burden Percent	100.00%	100.05%	100.00%	100.00%
Interest Burden Percent	94.83%	95.55%	97.24%	-138.44%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-126.46%	-226.80%	-747.37%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	-130.67%	-198.91%	-741.51%	0.00%
Return on Net Nonoperating Assets (RNNOA)	85.19%	169.88%	713.96%	0.00%
Return on Equity (ROE)	-41.27%	-56.93%	-33.41%	-7.74%
Cash Return on Invested Capital (CROIC)	-214.90%	-229.42%	-395.58%	0.00%
Operating Return on Assets (OROA)	-20.16%	-34.37%	-25.00%	4.09%
Return on Assets (ROA)	-19.11%	-32.85%	-24.31%	-5.66%
Return on Common Equity (ROCE)	-41.27%	-56.93%	-33.41%	-7.74%
Return on Equity Simple (ROE_SIMPLE)	-45.91%	-72.62%	-38.07%	-3.75%
Net Operating Profit after Tax (NOPAT)	-58	-62	-72	-39
NOPAT Margin	-55.47%	-76.83%	-130.07%	-165.38%
Net Nonoperating Expense Percent (NNEP)	4.22%	-27.90%	-5.87%	19.51%
Return On Investment Capital (ROIC_SIMPLE)	-48.97%	-	-	-
Cost of Revenue to Revenue	42.92%	57.93%	96.87%	82.78%
SG&A Expenses to Revenue	54.53%	52.34%	68.34%	84.94%
R&D to Revenue	22.57%	30.41%	34.01%	48.98%
Operating Expenses to Revenue	136.33%	151.82%	188.95%	253.47%
Earnings before Interest and Taxes (EBIT)	-57	-111	-89	7.87
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-39	-102	-83	11
Valuation Ratios	-	-	-	-
Price to Book Value (P/BV)	5.29	4.88	1.65	2.19
Price to Tangible Book Value (P/TBV)	5.29	4.88	1.65	2.19
Price to Revenue (P/Rev)	5.99	8.87	6.79	27.16
Price to Earnings (P/E)	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	8.68	21.55	6.49	0.00
Enterprise Value to Revenue (EV/Rev)	5.49	7.39	3.16	14.42
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	31.35
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	42.89
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-
Debt to Equity	0.00	0.00	0.13	0.03
Long-Term Debt to Equity	0.00	0.00	0.09	0.03
Financial Leverage	-0.65	-0.85	-0.96	-1.01
Leverage Ratio	2.16	1.73	1.37	1.37
Compound Leverage Factor	2.05	1.66	1.34	-1.89
Debt to Total Capital	0.00%	0.00%	11.56%	3.31%
Short-Term Debt to Total Capital	0.00%	0.00%	3.90%	0.67%
Long-Term Debt to Total Capital	0.00%	0.00%	7.67%	2.65%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	88.44%	96.69%
Debt to EBITDA	0.00	0.00	-0.36	0.92
Net Debt to EBITDA	0.00	0.00	2.40	-27.69
Long-Term Debt to EBITDA	0.00	0.00	-0.24	0.74
Debt to NOPAT	0.00	0.00	-0.41	-0.26
Net Debt to NOPAT	0.00	0.00	2.79	7.70
Long-Term Debt to NOPAT	0.00	0.00	-0.27	-0.21
Altman Z-Score	0.43	0.83	1.20	5.99
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-
Current Ratio	1.26	2.14	4.95	13.61
Quick Ratio	0.83	1.72	4.43	12.90
Cash Flow Metrics	-	-	-	-
Free Cash Flow to Firm (FCFF)	-98	-62	-106	-27
Operating Cash Flow to CapEx	-82.68%	-13.54%	-312.92%	-322.89%
Free Cash Flow to Firm to Interest Expense	0.00	-48.82	-149.37	-1.44
Operating Cash Flow to Interest Expense	0.00	-7.66	-104.96	-3.03
Operating Cash Flow Less CapEx to Interest Expense	0.00	-64.22	-138.50	-3.97
Efficiency Ratios	-	-	-	-
Asset Turnover	0.37	0.25	0.16	0.12
Accounts Receivable Turnover	4.16	2.95	2.88	5.94
Inventory Turnover	3.26	4.71	8.13	8.65
Fixed Asset Turnover	0.88	1.02	1.61	1.38
Accounts Payable Turnover	3.20	2.62	4.41	3.69
Days Sales Outstanding (DSO)	87.75	123.75	126.96	61.46
Days Inventory Outstanding (DIO)	111.80	77.42	44.88	42.19
Days Payable Outstanding (DPO)	114.19	139.43	82.74	98.79
Cash Conversion Cycle (CCC)	85.35	61.74	89.10	4.86
Capital & Investment Metrics	-	-	-	-
Invested Capital	66	28	27	-7.67
Invested Capital Turnover	2.28	2.95	5.75	-12.69
Increase / (Decrease) in Invested Capital	40	0.71	35	-12
Enterprise Value (EV)	570	595	174	337
Market Capitalization	622	713	375	635
Book Value per Share	$0.75	$0.97	$1.57	$2.04
Tangible Book Value per Share	$0.75	$0.97	$1.57	$2.04
Total Capital	118	146	257	300
Total Debt	0.00	0.00	30	9.95
Total Long-Term Debt	0.00	0.00	20	7.95
Net Debt	-52	-119	-200	-298
Capital Expenditures (CapEx)	37	72	24	18
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-27	-25	14	0.90
Debt-free Net Working Capital (DFNWC)	25	94	243	309
Net Working Capital (NWC)	25	94	233	307
Net Nonoperating Expense (NNE)	-3.60	44	15	-28
Net Nonoperating Obligations (NNO)	-52	-119	-200	-298
Total Depreciation and Amortization (D&A)	18	9.36	5.47	2.90
Debt-free, Cash-free Net Working Capital to Revenue	-26.19%	-31.00%	24.78%	3.84%
Debt-free Net Working Capital to Revenue	23.82%	116.64%	441.09%	1,320.01%
Net Working Capital to Revenue	23.82%	116.64%	422.97%	1,311.46%
Earnings Adjustments	-	-	-	-
Adjusted Basic Earnings per Share	($0.34)	($0.71)	$0.00	($0.15)
Adjusted Weighted Average Basic Shares Outstanding	156.57M	149.17M	0.00	71.66M
Adjusted Diluted Earnings per Share	($0.34)	($0.71)	$0.00	($0.15)
Adjusted Weighted Average Diluted Shares Outstanding	156.57M	149.17M	0.00	71.66M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	152.18M	0.00	143.30M
Normalized Net Operating Profit after Tax (NOPAT)	-57	-62	-71	-37
Normalized NOPAT Margin	-55.32%	-76.55%	-128.60%	-159.78%
Pre Tax Income Margin	-52.01%	-132.06%	-156.55%	-46.54%
Debt Service Ratios	-	-	-	-
EBIT to Interest Expense	0.00	-86.84	-124.80	0.42
NOPAT to Interest Expense	0.00	-48.27	-100.83	-2.06
EBIT Less CapEx to Interest Expense	0.00	-143.40	-158.34	-0.52
NOPAT Less CapEx to Interest Expense	0.00	-104.83	-134.37	-3.00
Payout Ratios	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	-313.48%

This table displays calculated financial ratios and metrics derived from Evolv Technologies' official financial filings.

Metric	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-
Revenue Growth	28.83%	16.61%	4.48%	22.15%	118.58%	113.33%	216.54%	96.23%
EBITDA Growth	110.11%	65.79%	44.87%	136.91%	-168.95%	-109.37%	-593.33%	-179.11%
EBIT Growth	104.05%	54.99%	37.68%	121.60%	-163.69%	-106.03%	-727.99%	-188.67%
NOPAT Growth	-35.00%	0.95%	18.30%	-8.69%	6.55%	5.75%	6.34%	3.82%
Net Income Growth	105.19%	59.30%	40.33%	132.23%	-159.88%	-107.30%	-691.14%	-189.47%
EPS Growth	104.44%	60.00%	52.63%	123.08%	-150.00%	-100.00%	-106.48%	-192.86%
Operating Cash Flow Growth	-311.18%	-368.35%	40.78%	112.39%	76.93%	88.33%	62.67%	30.27%
Free Cash Flow Firm Growth	-673.20%	-148.19%	69.91%	102.39%	-74.29%	-119.84%	0.00%	-150.40%
Invested Capital Growth	880.50%	172.72%	2.65%	-58.35%	-145.73%	35.66%	450.38%	211.13%
Revenue Q/Q Growth	17.87%	-0.70%	8.07%	1.85%	6.70%	-11.03%	26.35%	82.25%
EBITDA Q/Q Growth	174.32%	41.24%	-331.33%	110.01%	-151.55%	5.31%	-54.88%	27.09%
EBIT Q/Q Growth	121.85%	31.08%	-538.90%	106.13%	-142.58%	4.57%	-52.14%	25.13%
NOPAT Q/Q Growth	-43.17%	-1.70%	24.23%	-22.38%	-5.05%	16.12%	-0.80%	-5.22%
Net Income Q/Q Growth	129.73%	31.06%	-381.55%	108.99%	-133.33%	-1.08%	-52.05%	27.53%
EPS Q/Q Growth	125.00%	11.11%	-400.00%	106.67%	-125.00%	-5.26%	-46.15%	27.78%
Operating Cash Flow Q/Q Growth	-36.04%	-411.71%	-249.88%	139.41%	-54.95%	35.29%	68.65%	26.62%
Free Cash Flow Firm Q/Q Growth	-146.26%	-232.34%	-832.37%	-90.44%	206.63%	59.71%	41.82%	-202.84%
Invested Capital Q/Q Growth	62.17%	115.89%	72.36%	229.34%	-156.66%	-18.74%	-30.06%	42.01%
Profitability Metrics	-	-	-	-	-	-	-	-
Gross Margin	56.66%	54.33%	47.02%	56.41%	37.39%	25.64%	0.26%	1.36%
EBITDA Margin	26.35%	-41.79%	-70.62%	32.99%	-335.82%	-142.44%	-133.84%	-109.18%
Operating Margin	-87.42%	-102.82%	-100.39%	-100.24%	-119.17%	-121.04%	-128.39%	-160.93%
EBIT Margin	10.89%	-58.75%	-84.64%	20.84%	-346.06%	-152.21%	-141.90%	-117.84%
Profit (Net Income) Margin	13.56%	-53.74%	-77.40%	29.71%	-336.72%	-153.97%	-135.52%	-112.61%
Tax Burden Percent	100.00%	100.00%	100.30%	100.00%	100.00%	100.00%	100.00%	100.00%
Interest Burden Percent	124.49%	91.48%	91.17%	142.56%	97.30%	101.16%	95.51%	95.56%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-185.18%	-147.62%	-207.45%	-292.63%	-861.08%	-290.55%	-516.40%	-2,393.34%
ROIC Less NNEP Spread (ROIC-NNEP)	-209.39%	-150.61%	-206.48%	-307.62%	-835.31%	-284.78%	-512.57%	-2,393.34%
Return on Net Nonoperating Assets (RNNOA)	150.05%	115.11%	176.34%	266.21%	804.96%	262.45%	493.53%	2,376.04%
Return on Equity (ROE)	-35.13%	-32.51%	-31.11%	-26.42%	-56.12%	-28.10%	-22.87%	-17.30%
Cash Return on Invested Capital (CROIC)	-175.66%	-244.07%	-229.42%	-157.16%	0.00%	-403.57%	-395.58%	0.00%
Operating Return on Assets (OROA)	3.37%	-16.69%	-21.05%	5.24%	-81.87%	-30.50%	-22.03%	-13.61%
Return on Assets (ROA)	4.20%	-15.27%	-19.25%	7.47%	-79.65%	-30.85%	-21.04%	-13.01%
Return on Common Equity (ROCE)	-35.13%	-32.51%	-31.11%	-26.42%	-56.12%	-28.10%	-22.87%	-17.30%
Return on Equity Simple (ROE_SIMPLE)	-12.46%	-63.06%	0.00%	-75.37%	-98.70%	-49.65%	0.00%	-21.46%
Net Operating Profit after Tax (NOPAT)	-22	-16	-15	-20	-17	-16	-19	-19
NOPAT Margin	-87.42%	-71.97%	-70.27%	-100.24%	-83.42%	-84.73%	-89.87%	-112.65%
Net Nonoperating Expense Percent (NNEP)	24.22%	2.99%	-0.98%	14.99%	-25.77%	-5.77%	-3.83%	0.00%
Cost of Revenue to Revenue	43.34%	45.67%	52.98%	43.59%	62.61%	74.36%	99.74%	98.64%
SG&A Expenses to Revenue	55.54%	54.64%	50.49%	55.83%	54.85%	48.04%	40.46%	53.47%
R&D to Revenue	22.40%	28.64%	28.70%	31.74%	32.26%	29.00%	23.10%	33.97%
Operating Expenses to Revenue	144.08%	157.14%	147.41%	156.65%	156.56%	146.69%	128.65%	162.29%
Earnings before Interest and Taxes (EBIT)	2.78	-13	-18	4.21	-69	-28	-30	-19
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	6.73	-9.06	-15	6.66	-67	-26	-28	-18
Valuation Ratios	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.60	4.78	4.88	4.67	6.18	2.26	1.65	1.23
Price to Tangible Book Value (P/TBV)	2.60	4.78	4.88	4.67	6.18	2.26	1.65	1.23
Price to Revenue (P/Rev)	4.46	8.11	8.87	9.17	11.75	7.10	6.79	7.47
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	3.54	10.01	21.55	36.78	0.00	12.80	6.49	2.49
Enterprise Value to Revenue (EV/Rev)	3.83	7.14	7.39	7.41	9.68	4.30	3.16	2.34
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.13	0.04
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.09	0.02
Financial Leverage	-0.72	-0.76	-0.85	-0.87	-0.96	-0.92	-0.96	-0.99
Leverage Ratio	1.94	1.70	1.73	1.56	1.59	1.34	1.37	1.33
Compound Leverage Factor	2.41	1.56	1.58	2.23	1.54	1.36	1.31	1.27
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	11.56%	3.48%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	3.90%	1.55%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	7.67%	1.93%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	88.44%	96.52%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	-0.36	-0.18
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	2.40	4.22
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	-0.24	-0.10
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	-0.41	-0.13
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	2.79	3.13
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	-0.27	-0.07
Altman Z-Score	1.10	1.76	1.85	2.40	2.04	2.34	1.76	2.46
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-
Current Ratio	1.74	1.77	2.14	2.50	3.17	4.63	4.95	6.70
Quick Ratio	1.17	1.29	1.72	2.09	2.75	4.02	4.43	5.85
Cash Flow Metrics	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-131	-53	-16	2.19	23	-21	-53	-92
Operating Cash Flow to CapEx	-720.18%	-74.94%	-16.89%	10.99%	-25.74%	-24.46%	-112.84%	-260.48%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	-16.79	-239.14	-487.51
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	-2.68	-23.80	-90.03
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	-13.65	-44.89	-124.60
Efficiency Ratios	-	-	-	-	-	-	-	-
Asset Turnover	0.31	0.28	0.25	0.25	0.24	0.20	0.16	0.12
Accounts Receivable Turnover	2.59	3.70	2.95	3.12	3.40	4.10	2.88	2.87
Inventory Turnover	3.50	4.31	4.71	7.67	11.48	7.44	8.13	7.77
Fixed Asset Turnover	0.89	0.88	1.02	1.18	1.31	1.53	1.61	1.40
Accounts Payable Turnover	3.68	2.45	2.62	4.46	4.81	4.99	4.41	4.07
Days Sales Outstanding (DSO)	140.77	98.75	123.75	117.07	107.29	89.04	126.96	127.27
Days Inventory Outstanding (DIO)	104.38	84.79	77.42	47.56	31.80	49.09	44.88	47.00
Days Payable Outstanding (DPO)	99.30	148.74	139.43	81.76	75.86	73.15	82.74	89.76
Cash Conversion Cycle (CCC)	145.85	34.80	61.74	82.87	63.24	64.98	89.10	84.51
Capital & Investment Metrics	-	-	-	-	-	-	-	-
Invested Capital	97	60	28	16	-12	22	27	38
Invested Capital Turnover	2.12	2.05	2.95	2.92	10.32	3.43	5.75	21.25
Increase / (Decrease) in Invested Capital	109	38	0.71	-22	-39	5.74	35	73
Enterprise Value (EV)	342	596	595	589	734	280	174	96
Market Capitalization	398	677	713	729	891	462	375	306
Book Value per Share	$0.98	$0.93	$0.97	$1.04	$0.97	$1.38	$1.57	$1.72
Tangible Book Value per Share	$0.98	$0.93	$0.97	$1.04	$0.97	$1.38	$1.57	$1.72
Total Capital	153	142	146	156	144	204	257	257
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	30	8.96
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	20	4.96
Net Debt	-56	-81	-119	-140	-157	-182	-200	-210
Capital Expenditures (CapEx)	3.04	21	19	19	21	14	4.70	6.50
Debt-free, Cash-free Net Working Capital (DFCFNWC)	2.04	-19	-25	-19	-8.62	2.18	14	19
Debt-free Net Working Capital (DFNWC)	58	62	94	121	148	184	243	238
Net Working Capital (NWC)	58	62	94	121	148	184	233	234
Net Nonoperating Expense (NNE)	-26	-3.95	1.56	-26	50	13	9.53	-0.01
Net Nonoperating Obligations (NNO)	-56	-82	-119	-140	-157	-182	-200	-210
Total Depreciation and Amortization (D&A)	3.95	3.67	3.06	2.45	2.03	1.82	1.68	1.43
Debt-free, Cash-free Net Working Capital to Revenue	2.28%	-22.91%	-31.00%	-23.98%	-11.36%	3.34%	24.78%	46.15%
Debt-free Net Working Capital to Revenue	65.56%	74.10%	116.64%	152.29%	195.09%	283.05%	441.09%	581.25%
Net Working Capital to Revenue	65.56%	74.10%	116.64%	152.29%	195.09%	283.05%	422.97%	571.47%
Earnings Adjustments	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.02	($0.08)	($0.10)	$0.04	$0.00	($0.20)	($0.19)	$0.00
Adjusted Weighted Average Basic Shares Outstanding	156.47M	153.08M	149.17M	150.21M	0.00	146.43M	143.86M	0.00
Adjusted Diluted Earnings per Share	$0.02	($0.08)	($0.09)	$0.03	$0.00	($0.20)	($0.19)	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	171.56M	153.08M	149.17M	173.98M	0.00	146.43M	143.86M	0.00
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	157.55M	156.09M	152.18M	151.13M	0.00	148.43M	147.96M	0.00
Normalized Net Operating Profit after Tax (NOPAT)	-16	-16	-15	-14	-16	-16	-19	-18
Normalized NOPAT Margin	-61.19%	-71.97%	-70.27%	-70.07%	-82.87%	-84.21%	-89.46%	-110.00%
Pre Tax Income Margin	13.56%	-53.74%	-77.17%	29.71%	-336.72%	-153.97%	-135.52%	-112.61%
Debt Service Ratios	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	-22.10	-132.89	-103.61
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	-12.30	-84.17	-99.05
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	-33.06	-153.98	-138.18
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	-23.27	-105.26	-133.61
Payout Ratios	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions About Evolv Technologies' Financials

When does Evolv Technologies's financial year end?

According to the most recent income statement we have on file, Evolv Technologies' fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Evolv Technologies' net income changed over the last 3 years?

Evolv Technologies' net income appears to be on an upward trend, with a most recent value of -$54.02 million in 2024, rising from -$10.89 million in 2021. The previous period was -$106.25 million in 2023. See where experts think Evolv Technologies is headed by visiting Evolv Technologies' forecast page.

What is Evolv Technologies's operating income?

Evolv Technologies's total operating income in 2024 was -$82.31 million, based on the following breakdown:

Total Gross Profit: $59.29 million
Total Operating Expenses: $141.60 million

How has Evolv Technologies revenue changed over the last 3 years?

Over the last 3 years, Evolv Technologies' total revenue changed from $23.39 million in 2021 to $103.87 million in 2024, a change of 344.0%.

How much debt does Evolv Technologies have?

Evolv Technologies' total liabilities were at $150.41 million at the end of 2024, a 1.3% decrease from 2023, and a 107.2% increase since 2021.

How much cash does Evolv Technologies have?

In the past 3 years, Evolv Technologies' cash and equivalents has ranged from $37.02 million in 2024 to $307.49 million in 2021, and is currently $37.02 million as of their latest financial filing in 2024.

How has Evolv Technologies' book value per share changed over the last 3 years?

Over the last 3 years, Evolv Technologies' book value per share changed from 2.04 in 2021 to 0.75 in 2024, a change of -63.4%.

Related Companies

This page (NASDAQ:EVLV) was last updated on 5/21/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Evolv Technologies (EVLV) Financials

Frequently Asked Questions About Evolv Technologies' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Evolv Technologies (EVLV) Financials

Annual Income Statements for Evolv Technologies

Quarterly Income Statements for Evolv Technologies

Annual Cash Flow Statements for Evolv Technologies

Quarterly Cash Flow Statements for Evolv Technologies

Annual Balance Sheets for Evolv Technologies

Quarterly Balance Sheets for Evolv Technologies

Annual Metrics And Ratios for Evolv Technologies

Quarterly Metrics And Ratios for Evolv Technologies

Frequently Asked Questions About Evolv Technologies' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools